{"id": 1513509405706309637, "geo": null, "lang": "en", "text": "Teva is honored to be an investor in the AMR Action Fund and a part of this work to identify urgently needed treatm\u2026 https://t.co/JNK7FEm3VN", "user": {"id": 183626808, "url": "https://t.co/cFgvG59N2C", "lang": null, "name": "Teva Pharmaceuticals", "id_str": "183626808", "entities": {"url": {"urls": [{"url": "https://t.co/cFgvG59N2C", "indices": [0, 23], "display_url": "tevausa.com", "expanded_url": "http://www.tevausa.com"}]}, "description": {"urls": [{"url": "https://t.co/sOC1rpJ9tr", "indices": [128, 151], "display_url": "bit.ly/TevaSocialUSA", "expanded_url": "http://bit.ly/TevaSocialUSA"}]}}, "location": "United States", "verified": false, "following": true, "protected": false, "time_zone": null, "created_at": "Fri Aug 27 13:45:33 +0000 2010", "utc_offset": null, "description": "Official Teva US Twitter feed. We don't just make medicines, we make a difference in people's lives. By Corp Comms. Guidelines: https://t.co/sOC1rpJ9tr", "geo_enabled": false, "screen_name": "TevaUSA", "listed_count": 166, "friends_count": 1093, "is_translator": false, "notifications": false, "statuses_count": 2960, "default_profile": false, "followers_count": 9849, "translator_type": "none", "favourites_count": 1028, "profile_image_url": "http://pbs.twimg.com/profile_images/1114240566001315840/wwBtyZu1_normal.png", "profile_banner_url": "https://pbs.twimg.com/profile_banners/183626808/1657116200", "profile_link_color": "94D487", "profile_text_color": "000000", "follow_request_sent": false, "contributors_enabled": false, "has_extended_profile": false, "default_profile_image": false, "withheld_in_countries": [], "is_translation_enabled": false, "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/1114240566001315840/wwBtyZu1_normal.png", "profile_background_color": "94D487", "profile_sidebar_fill_color": "000000", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "000000", "profile_use_background_image": false, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "1513509405706309637", "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "entities": {"urls": [{"url": "https://t.co/JNK7FEm3VN", "indices": [117, 140], "display_url": "twitter.com/i/web/status/1\u2026", "expanded_url": "https://twitter.com/i/web/status/1513509405706309637"}], "symbols": [], "hashtags": [], "user_mentions": []}, "favorited": false, "retweeted": false, "truncated": true, "created_at": "Mon Apr 11 13:28:56 +0000 2022", "coordinates": null, "contributors": null, "quoted_status": {"id": 1510923353149816836, "geo": null, "lang": "en", "text": "We are absolutely thrilled to welcome @AdaptivePhageTx and @VenatorxPharma as our first portfolio companies! Learn\u2026 https://t.co/CIilU1yPQA", "user": {"id": 1270709401192718337, "url": "https://t.co/PL1mqhsnfM", "lang": null, "name": "AMR Action Fund", "id_str": "1270709401192718337", "entities": {"url": {"urls": [{"url": "https://t.co/PL1mqhsnfM", "indices": [0, 23], "display_url": "amractionfund.com", "expanded_url": "https://amractionfund.com/"}]}, "description": {"urls": []}}, "location": "Boston, MA", "verified": false, "following": false, "protected": false, "time_zone": null, "created_at": "Wed Jun 10 13:28:55 +0000 2020", "utc_offset": null, "description": "We are a groundbreaking venture fund investing approximately US$1 billion to bring 2 to 4 new antimicrobials to patients by the end of the decade.", "geo_enabled": false, "screen_name": "AMRActionFund", "listed_count": 18, "friends_count": 269, "is_translator": false, "notifications": false, "statuses_count": 1125, "default_profile": true, "followers_count": 2734, "translator_type": "none", "favourites_count": 1484, "profile_image_url": "http://pbs.twimg.com/profile_images/1551590439597363200/H5mJKxmE_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/1270709401192718337/1658937364", "profile_link_color": "1DA1F2", "profile_text_color": "333333", "follow_request_sent": false, "contributors_enabled": false, "has_extended_profile": false, "default_profile_image": false, "withheld_in_countries": [], "is_translation_enabled": false, "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/1551590439597363200/H5mJKxmE_normal.jpg", "profile_background_color": "F5F8FA", "profile_sidebar_fill_color": "DDEEF6", "profile_background_image_url": null, "profile_sidebar_border_color": "C0DEED", "profile_use_background_image": true, "profile_background_image_url_https": null}, "place": null, "id_str": "1510923353149816836", "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "entities": {"urls": [{"url": "https://t.co/CIilU1yPQA", "indices": [116, 139], "display_url": "twitter.com/i/web/status/1\u2026", "expanded_url": "https://twitter.com/i/web/status/1510923353149816836"}], "symbols": [], "hashtags": [], "user_mentions": [{"id": 1072268696800948224, "name": "Adaptive Phage Therapeutics", "id_str": "1072268696800948224", "indices": [38, 54], "screen_name": "AdaptivePhageTx"}, {"id": 1044593715434721285, "name": "Venatorx Pharmaceuticals", "id_str": "1044593715434721285", "indices": [59, 74], "screen_name": "VenatorxPharma"}]}, "favorited": false, "retweeted": false, "truncated": true, "created_at": "Mon Apr 04 10:12:53 +0000 2022", "coordinates": null, "contributors": null, "retweet_count": 26, "favorite_count": 75, "is_quote_status": false, "possibly_sensitive": false, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}, "retweet_count": 0, "favorite_count": 5, "is_quote_status": true, "quoted_status_id": 1510923353149816836, "possibly_sensitive": false, "in_reply_to_user_id": null, "quoted_status_id_str": "1510923353149816836", "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}